Effect of gemfibrozil versus lovastatin on increased serum lipoprotein(a) levels of patients with hypercholesterolemia
- 28 February 1995
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 48 (2), 115-120
- https://doi.org/10.1016/0167-5273(94)02221-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Quantitation of Plasma Apolipoproteins in the Primary and Secondary Prevention of Coronary Artery DiseaseAnnals of Internal Medicine, 1994
- The Efficacy of Intensive Dietary Therapy Alone or Combined with Lovastatin in Outpatients with HypercholesterolemiaNew England Journal of Medicine, 1993
- Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigationClinica Chimica Acta; International Journal of Clinical Chemistry, 1991
- Simvastatin in severe hypercholesterolaemia: a placebo controlled trial.British Journal of Clinical Pharmacology, 1991
- Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acidJournal of Internal Medicine, 1989
- Lipoprotein Lp(a). A risk factor for myocardial infarction.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of Internal Medicine, 1988
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.Circulation, 1986
- Levels of lipoprotein Lp(a) decline with neomycin and niacin treatmentAtherosclerosis, 1985